VKTX
Viking Therapeutics, Inc.NasdaqResearch view
HealthcarePharmaceutical PreparationsSEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Income—
Sales$0
Book/sh$5.48
Cash/sh$1.42
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio—
Current Ratio9.33
Debt/Eq—
EPS (ttm)$-3.19
EPS this Y-215.8%
EPS past 3/5Y—
Sales past 3/5Y—
EPS Y/Y TTM-215.8%
Sales Y/Y TTM—
Shs Outstand116.65M
ROA—
ROE—
ROIC-83.1%
Gross Margin—
Oper. Margin—
Profit Margin—
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$0
2021
$0
2022
$0
2023
$0
2024
$0
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | $-55.7M | $-70.4M | $-100.8M | $-150.9M | $-393.3M |
| Net Income | $-55.0M | $-68.9M | $-85.9M | $-110.0M | $-359.6M |
| Diluted EPS | $-0.71 | $-0.90 | $-0.91 | $-1.01 | $-3.19 |
| Operating Cash Flow | $-47.6M | $-48.4M | $-73.4M | $-87.8M | $-278.7M |
| Free Cash Flow | — | — | — | — | — |
Follow the news. Track the move.
VKTX story timeline
Company updates and connected market context, with the dated price move attached.
1
Stories
0
Direct
COMMUNITY · $VKTX0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.